4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-21-050719
Chief Financial Officer sold 25,000 shares at an average $138.52 ($3,462,926)
- Chief Financial Officer acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…